Ann Schwartz, Ph.D., M.P.H
Terrance Albrecht, Ph.D.
Patricia LoRusso, D.O.
Anthony Shields, M.D., Ph.D.
Wei-Zen Wei, Ph.D.
Ann Schwartz, Ph.D., M.P.H., assumes the position of deputy center director and executive vice president of Research and Academic Affairs. Dr. Schwartz served as interim president and chief executive officer of Karmanos before Dr. Bepler’s arrival. She has served as associate center director for Population Sciences at Karmanos since 2002.
Terrance Albrecht, Ph.D., a professor in the Department of Family Medicine and Public Health Sciences at the School of Medicine, continues as permanent associate center director for Population Research. Dr. Albrecht joined Karmanos in 2003 and most recently led the Communication and Behavioral Oncology program. She also served as co-leader of the Population Studies and Prevention program.
Patricia LoRusso, D.O., professor of Internal Medicine for the School of Medicine, is director for the new Center for Experimental Therapeutics. Dr. LoRusso developed the Phase I program at Karmanos, one of only 14 National Cancer Institute-funded Phase I programs in the United States and Canada, and the only such program in Michigan.
Anthony Shields, M.D., Ph.D., professor of Internal Medicine and Oncology for the School of Medicine, continues as associate center director of Clinical Research. Dr. Shields is a well-recognized physician-scientist who works in the area of anti-cancer drug assessment.
Wei-Zen Wei, Ph.D., professor of Immunology and Microbiology for the School of Medicine, is the new associate center director for Basic Research. Dr. Wei has worked on cancer-fighting vaccines since 1996 to help prevent HER2-positive breast cancer, which accounts for 20 percent to 30 percent of cases and is characterized by tumors that grow faster and are more likely to recur. Her lab was the first to develop the HER2 DNA vaccine, which was tested in the laboratory on tumors that no longer responded to other HER2-positive breast cancer therapies.
“I’m honored to work with these brilliant and talented physicians and scientists,” Dr. Bepler said. “Their lifelong commitment and drive to fight cancer is a testament to the scientific and medical professions. It’s this level of expertise that continues to move the Karmanos Cancer Institute closer to being one of the top 10 cancer centers in the country.”